CSRP3 Gene Cardiomyopathy familial hypertrophic type 12 Genetic Test
At DNA Labs UAE, we offer the CSRP3 Gene Cardiomyopathy familial hypertrophic type 12 Genetic Test. This test is designed to detect mutations in the CSRP3 gene, which is associated with familial hypertrophic cardiomyopathy.
Test Components
- CSRP3 Gene Cardiomyopathy familial hypertrophic type 12 Genetic Test
Price
The cost of the CSRP3 Gene Cardiomyopathy familial hypertrophic type 12 Genetic Test is 4400.0 AED.
Sample Condition
We accept blood samples or extracted DNA samples for this test. Alternatively, you can provide one drop of blood on an FTA card.
Report Delivery
You can expect to receive your test results within 3 to 4 weeks.
Method
We use NGS (Next-Generation Sequencing) technology for this genetic test.
Test Type
The CSRP3 Gene Cardiomyopathy familial hypertrophic type 12 Genetic Test falls under the category of Cardiovascular Pneumology Disorders.
Doctor
This test is conducted by our experienced Cardiologist.
Test Department
The CSRP3 Gene Cardiomyopathy familial hypertrophic type 12 Genetic Test is conducted in our Genetics department.
Pre Test Information
Before undergoing the CSRP3 Gene Cardiomyopathy familial hypertrophic type 12 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by CSRP3 Gene Cardiomyopathy familial hypertrophic type 12 NGS Genetic DNA Test gene CSRP3.
Test Details
The CSRP3 Gene Cardiomyopathy familial hypertrophic type 12 is a genetic disorder that affects the heart muscle. It is caused by mutations in the CSRP3 gene, which is responsible for the production of a protein called cysteine and glycine-rich protein 3.
This type of cardiomyopathy is inherited in an autosomal dominant pattern, meaning that a mutation in one copy of the CSRP3 gene is enough to cause the condition. However, it is important to note that some individuals with this mutation may not display any symptoms, while others may develop hypertrophic cardiomyopathy, a condition characterized by the thickening of the heart muscle.
NGS genetic testing, also known as next-generation sequencing genetic testing, is a type of genetic test that can analyze multiple genes simultaneously. In the case of CSRP3 Gene Cardiomyopathy familial hypertrophic type 12, this test can identify mutations or variants in the CSRP3 gene, as well as other genes associated with cardiomyopathies.
This type of testing is valuable for diagnosing individuals with familial hypertrophic cardiomyopathy and providing information about the specific genetic cause of the condition. It can also be beneficial for identifying those at risk within families with a history of the condition, guiding appropriate management and treatment strategies, and assisting with genetic counseling and family planning decisions.
| Test Name | CSRP3 Gene Cardiomyopathy familial hypertrophic type 12 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cardiovascular Pneumology Disorders |
| Doctor | Cardiologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CSRP3 Gene Cardiomyopathy, familial hypertrophic type 12 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CSRP3 Gene Cardiomyopathy, familial hypertrophic type 12 NGS Genetic DNA Test gene CSRP3 |
| Test Details |
CSRP3 gene cardiomyopathy, familial hypertrophic type 12 is a genetic disorder that affects the heart muscle. It is caused by mutations in the CSRP3 gene, which provides instructions for making a protein called cysteine and glycine-rich protein 3. This type of cardiomyopathy is inherited in an autosomal dominant pattern, which means that a mutation in one copy of the CSRP3 gene is sufficient to cause the condition. However, some individuals with this mutation may not show any symptoms, while others may develop hypertrophic cardiomyopathy, a condition characterized by the thickening of the heart muscle. NGS genetic testing, or next-generation sequencing genetic testing, is a type of genetic test that can analyze multiple genes simultaneously. It can identify mutations or variants in the CSRP3 gene and other genes associated with cardiomyopathies. This type of testing can help diagnose individuals with familial hypertrophic cardiomyopathy and provide information about the specific genetic cause of the condition. Genetic testing for CSRP3 gene cardiomyopathy can be beneficial for individuals with a family history of the condition, as it can help identify those at risk and guide appropriate management and treatment strategies. It can also be useful for genetic counseling and family planning purposes. |
